<DOC>
	<DOC>NCT02942615</DOC>
	<brief_summary>Under the modern precise radiotherapy technology, clear the best dose volume limit index and the limit value for the primary level prevention of heart injury; clear best follow-up interval and measures for heart function of breast cancer patients, to achieve the secondary prevention of cardiac injury; explore combined cardiovascular specialist optimal treatment strategy for heart injury in the treatment of breast cancer, during the tertiary prevention of cardiac injury; put forward rationalization proposal for prevention, treatment and follow-up for breast cancer associated with heart injury.</brief_summary>
	<brief_title>The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>Patients willing to participate the research and sign the informed consent file; Patients aged 1880 years; KPS≥70; Pathological diagnosis for invasive breast cancer; Patients received anthracycline/paclitaxel based chemotherapy, or herceptin based targeted therapy; No functional heart disease; LVEF≥50%; Patients received breast conserving surgery; Patients received modified radical mastectomy: T12 with N13 or T34 with any N; Tumor margin negative; No metastases; No other malignant tumor history. Patients with metastases; Tumor margin positive; Patients received modified radical mastectomy with T12 and N0; Patients have other malignant tumor; Patients have a history of heart disease; Patients received chest radiotherapy previously; Patients with severe organic and functional disease; Unqualified patients with sufficient reasons; Cannot or no willing to sign the informed consent file; Patients with autoimmune disease; Women with pregnancy, planned pregnancy or lactating.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>